Concepedia

Publication | Closed Access

Comparison of octreotide acetate LAR and lanreotide SR in patients with acromegaly

DOI

107

Citations

26

References

2000

Year

Philippe Chanson, Viktor Boerlin, Christiane Ajzenberg, Y. Bachelot, Pedro J. Benito, J. Bringer, Philippe Caron, B Charbonnel, Christine Cortet, Brigitte Delemer,
Clinical Endocrinology

Abstract

Octreotide LAR 20 mg administered once monthly was more effective than lanreotide SR 30 mg administered 2 or 3 times monthly in reducing GH and IGF-I in patients with acromegaly.

References

YearCitations

Page 1